Ophthalmic diseases evidently affect people’s daily lives. Nonarteritic anterior ischemic optic neuropathy (NAION) is an acute optic neuropathy and has a complex etiology and pathogenesis. NAION causes acute ischemia and structural and functional disorders of the optic nerve resulting from insufficient perfusion of the short posterior ciliary artery. NAION may cause irreversible vision loss, visual field defects, and even blindness if it is not treated early. There is no definite and standard treatment plan for NAION. To treat NAION more effectively, herein, we reviewed the clinical treatment of NAION in recent years and the latest treatment research progress, which will provide a systematic guidance for the treatment of NAION.

Shizhou Cheng, Chuyun Xing, Zuhai Zhang. New Research Advances in the Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 10: 16-23. https://doi.org/10.25236/IJFM.2022.041004.

[1] M. H. Sun, C. Y. Lee, Y. J. Liao, and C. C. Sun, Nonarteritic anterior ischaemic optic neuropathy and its association with obstructive sleep apnoea: a health insurance database study. Acta Ophthalmol, 2019. 97(1): p. e64-e70.

[2] S. Berry, W. V. Lin, A. Sadaka, and A. G. Lee, Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management. Eye Brain, 2017. 9: p. 23-28.

[3] Y. Wu, L. M. Zhou, H. Lou, J. W. Cheng, and R. L. Wei, The Association Between Obstructive Sleep Apnea and Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis. Curr Eye Res, 2016. 41(7): p. 987-92.

[4] S. Moghimi et al., Crowded optic nerve head evaluation with optical coherence tomography in anterior ischemic optic neuropathy. Eye (Lond), 2017. 31(8): p. 1191-1198.

[5] N. R. Miller and A. C. Arnold, Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye (Lond), 2015. 29(1): p. 65-79.

[6] L. Xu, Y. Wang, and J. B. Jonas, Incidence of nonarteritic anterior ischemic optic neuropathy in adult Chinese: the Beijing Eye Study. Eur J Ophthalmol, 2007. 17(3): p. 459-60.

[7] M. A. Warner, Cracking open the door on perioperative visual loss. Anesthesiology, 2012. 116(1): p. 1-2.

[8] W. Zhou et al., Clinical effect of hyperbaric oxygen combined therapy on patients with non-arteritic anterior ischemic optic neuropathy. Chinese Journal of Nautical Medicine and Hyperbaric Medicine, 2021. 28(1): p. 5 (in Chinese).

[9] A. G. Distefano and B. L. Lam, Non-Arteritic Anterior Ischemic Optic Neuropathy in Pilots. Aerosp Med Hum Perform, 2018. 89(11): p. 1005-1007.

[10] L. Lavie, Oxidative stress in obstructive sleep apnea and intermittent hypoxia--revisited--the bad ugly and good: implications to the heart and brain. Sleep Med Rev, 2015. 20: p. 27-45.

[11] A. Maniaci et al., Oxidative Stress and Inflammation Biomarker Expression in Obstructive Sleep Apnea Patients. J Clin Med, 2021. 10(2).

[12] A. Gabryelska, Z. M. Lukasik, J. S. Makowska, and P. Bialasiewicz, Obstructive Sleep Apnea: From Intermittent Hypoxia to Cardiovascular Complications via Blood Platelets. Front Neurol, 2018. 9: p. 635.

[13] F. F. de Lima, D. R. Mazzotti, S. Tufik, and L. Bittencourt, The role inflammatory response genes in obstructive sleep apnea syndrome: a review. Sleep Breath, 2016. 20(1): p. 331-8.

[14] J. W. Ycas, Toward a Blood-Borne Biomarker of Chronic Hypoxemia: Red Cell Distribution Width and Respiratory Disease. Adv Clin Chem, 2017. 82: p. 105-197.

[15] J. Chen, J. Zhu, L. Chen, C. Hu, and Y. Du, Steroids in the treatment of nonarteritic anterior ischemic optic neuropathy: A PRISMA-compliant meta-analysis. Medicine (Baltimore), 2019. 98(46): p. e17861.

[16] A. Pahor and D. Pahor, [Development of Non-Arteritic Anterior Ischaemic Optic Neuropathy in the Initially Unaffected Fellow Eye in Patients Treated with Systemic Corticosteroids]. Klin Monbl Augenheilkd, 2017. 234(11): p. 1396-1403.

[17] L. Li, Y. Su, J. Liu, and C. Chen, Efficacy of Vincamine treatment in a rat model of anterior ischemic optic neuropathy. Eur J Ophthalmol, 2021. 31(6): p. 3442-3449.

[18] M. A. Nguyen Ngo Le, Y. T. Wen, Y. C. Ho, K. Kapupara, and R. K. Tsai, Therapeutic Effects of Puerarin Against Anterior Ischemic Optic Neuropathy Through Antiapoptotic and Anti-Inflammatory Actions. Invest Ophthalmol Vis Sci, 2019. 60(10): p. 3481-3491.

[19] Q. Wang, S. Gao, Y. Luo, and Q. Y. Kang, Compound anisodine affects the proliferation and calcium overload of hypoxia-induced rat retinal progenitor cells and brain neural stem cells via the p-ERK1/2/HIF-1alpha/VEGF pathway. Exp Ther Med, 2017. 14(1): p. 600-608.

[20] W. Zhang, J. Zhao, C. Guo, X. Du, X. Yang, and C. Fang, Meta-analysis of the safety and effect of breviscapine combined with mecobalamin for diabetic peripheral neuropathy. Chinese Traditional Patent Medicine 2016. 38(5): p. 10 (in Chinese).

[21] A. M. Aftab, M. Iqbal, A. Rauf, and A. Ali, Non arteritic anterior ischemic optic neuropathy; does Anticoagulation help? J Ayub Med Coll Abbottabad, 2016. 28(4): p. 776-780.

[22] R. Foroozan, New Treatments for Nonarteritic Anterior Ischemic Optic Neuropathy. Neurol Clin, 2017. 35(1): p. 1-15.

[23] K. Dickersin and T. Li, Surgery for nonarteritic anterior ischemic optic neuropathy. Cochrane Database Syst Rev, 2015(3): p. CD001538.

[24] M. Soheilian, A. Koochek, S. Yazdani, and G. A. Peyman, Transvitreal optic neurotomy for nonarteritic anterior ischemic optic neuropathy. Retina, 2003. 23(5): p. 692-7.

[25] J. L. Bennett, S. Thomas, J. L. Olson, and N. Mandava, Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol, 2007. 27(3): p. 238-40.

[26] V. P. Dave and R. R. Pappuru, An unusual presentation of nonarteritic ischemic optic neuropathy with subretinal fluid treated with intravitreal bevacizumab. Indian J Ophthalmol, 2016. 64(1): p. 87-8.

[27] D. B. Rootman, H. S. Gill, and E. A. Margolin, Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial. Eye (Lond), 2013. 27(4): p. 538-44.

[28] Y. Feng, P. V. LoGrasso, O. Defert, and R. Li, Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential. J Med Chem, 2016. 59(6): p. 2269-300.

[29] Z. A. Nizamudeen, L. Chakrabarti, and V. Sottile, Exposure to the ROCK inhibitor fasudil promotes gliogenesis of neural stem cells in vitro. Stem Cell Res, 2018. 28: p. 75-86.

[30] N. Sanjari et al., Intravitreal Injection of a Rho-Kinase Inhibitor (Fasudil) for Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy. J Clin Pharmacol, 2016. 56(6): p. 749-53.

[31] S. Pankratova et al., Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor. Brain, 2010. 133(Pt 8): p. 2281-94.

[32] M. Modarres et al., Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol, 2011. 95(7): p. 992-5.

[33] T. N. Lin et al., 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol, 2006. 26(3): p. 481-7.

[34] N. R. Miller, M. A. Johnson, T. Nolan, Y. Guo, A. M. Bernstein, and S. L. Bernstein, Sustained neuroprotection from a single intravitreal injection of PGJ(2) in a nonhuman primate model of nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci, 2014. 55(11): p. 7047-56.

[35] C. H. Chang, T. L. Huang, S. P. Huang, and R. K. Tsai, Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in a rat model of anterior ischemic optic neuropathy (rAION). Exp Eye Res, 2014. 118: p. 109-16.

[36] K. Abri Aghdam et al., Intravitreal Injection Of The Granulocyte-Colony Stimulating Factor For The Treatment Of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Pilot Study. Semin Ophthalmol, 2021. 36(8): p. 649-657.

[37] Z. Ahmed et al., Ocular neuroprotection by siRNA targeting caspase-2. Cell Death Dis, 2011. 2: p. e173.

[38] E. C. Solano, D. J. Kornbrust, A. Beaudry, J. W. Foy, D. J. Schneider, and J. D. Thompson, Toxicological and pharmacokinetic properties of QPI-1007, a chemically modified synthetic siRNA targeting caspase 2 mRNA, following intravitreal injection. Nucleic Acid Ther, 2014. 24(4): p. 258-66.

[39] Y. S. Han et al., C-Met-Activated Mesenchymal Stem Cells Rescue Ischemic Damage via Interaction with Cellular Prion Protein. Cell Physiol Biochem, 2018. 46(5): p. 1835-1848.

[40] C. B. Liu et al., Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia. Stem Cells Transl Med, 2016. 5(8): p. 1004-13.

[41] L. Li et al., Preconditioning of bone marrow-derived mesenchymal stromal cells by tetramethylpyrazine enhances cell migration and improves functional recovery after focal cerebral ischemia in rats. Stem Cell Res Ther, 2017. 8(1): p. 112.

[42] B. Yu et al., Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1. Sci Rep, 2016. 6: p. 34562.

[43] Y. Xiao, F. Geng, G. Wang, X. Li, J. Zhu, and W. Zhu, Bone marrow-derived mesenchymal stem cells-derived exosomes prevent oligodendrocyte apoptosis through exosomal miR-134 by targeting caspase-8. J Cell Biochem, 2018.

[44] B. Yu, X. R. Li, and X. M. Zhang, Mesenchymal stem cell-derived extracellular vesicles as a new therapeutic strategy for ocular diseases. World J Stem Cells, 2020. 12(3): p. 178-187.

[45] D. Li and Y. Gong, A Promising Strategy for Non-Arteritic Anterior Ischemic Optic Neuropathy: Intravitreal Mesenchymal Stem Cell Exosome. Curr Stem Cell Res Ther, 2021. 16(2): p. 109-114.

[46] C. Merino-Gonzalez et al., Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Angiogenesis: Potencial Clinical Application. Front Physiol, 2016. 7: p. 24.

[47] B. Mead and S. Tomarev, Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms. Stem Cells Transl Med, 2017. 6(4): p. 1273-1285.

[48] Y. Song, J. Y. Min, L. Mao, and Y. Y. Gong, Microvasculature dropout detected by the optical coherence tomography angiography in nonarteritic anterior ischemic optic neuropathy. Lasers Surg Med, 2018. 50(3): p. 194-201.

[49] E. Moisseiev et al., Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia. Curr Eye Res, 2017. 42(10): p. 1358-1367.

[50] J. N. Weiss, S. Levy, and S. C. Benes, Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION). Stem Cell Investig, 2017. 4: p. 94.

[51] A. Liu, X. Tan, and X. Liu, Efficacy of Puerarin injection combined with conventional western medicines in treatment of patients with early acute anterior ischemic optic neuropathy and its effects on hemorheology. Medical Journal of Chinese People's Healt, 2019. 31(8): p. 3 (in Chinese).

[52] P. K. Liu, Y. T. Wen, W. Lin, K. Kapupara, M. Tai, and R. K. Tsai, Neuroprotective effects of low-dose G-CSF plus meloxicam in a rat model of anterior ischemic optic neuropathy. Sci Rep, 2020. 10(1): p. 10351.

[53] Y. Liu, H. Tan, J. Ran, and F. Wan, Effect of Buqi Huoxue Huayu Tongluo recipe on visual acuity, visual field, hemodynamics and flash electro-retinogram in patients with non - arteritis anterior ischemic optic neuropathy of qi deficiency and blood stasis type. Hebei J TCM, 2020. 42(3): p. 6 (in Chinese).

[54] H. Yang and J. Han, Retrospective Research of 90 cases of TCM Syndrome and Treatment in Anterior Ischemir Optic Neuropathy. Journal of Liaoning University of Traditional Chinese Medicine, 2018. 020(005): p. 208-211 (in Chinese).

[55] Y. Wang, H. Guo, Z. Zhao, L. Yu, and P. Bai, Study on electroacupuncture along the visual conductive pathway for ocular cell apoptosis in anterior ischemic optic neuropathy. Chinese Acupuncture & Moxibustion, 2017. 37(8): p. 6 (in Chinese).

[56] Y. Su, H. Liu, Y. Guo, and Z. Du, Clinical observation on the treatment of ischemic optic neuropathy by acupuncture in Chinese medicine. Guide of China Medicine, 2019. 17(32): p. 1(in Chinese).

[57] D. Zhao, The Clinical Research into anterior ischemic optic neurpathy Treated with Modified Huoxue Tongluo Decoction. Henan Traditional Chinese Medicine, 2017. 37(6): p. 3(in Chinese).